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A new study by Shimono et al. (2009) demonstrates that certain microRNAs that regulate the 
self-renewal factor BMI1 are downregulated in purified populations of normal mammary epithelial 
stem cells and breast tumor-initiating cells. These findings have important implications for the 
regulation of self-renewal and differentiation by microRNAs and suggest new ways of targeting 
cancer stem cells.Analyzing tumors may be akin to watch-
ing a baseball game from the last row 
of the bleachers. You easily perceive 
the hits and big defensive plays, but the 
essence of the dual between pitcher 
and batter, the heart of the game itself, 
is difficult to appreciate when you view 
the game from a distance. As well, the 
complex strategies used to get the bat-
ter out, involving a knowledge of the 
batter’s weaknesses, and a repertoire 
of different pitches to prevent hits, may 
not be readily apparent. A 
new study in this issue of Cell 
by Mike Clarke and his team 
(Shimono et al., 2009) rein-
forces the notion that fresh 
molecular insights into can-
cer, at least for some impor-
tant human tumors, may only 
come from purifying the cell 
subpopulations that lie at 
the heart of tumor growth. 
The yield of such an analy-
sis is potentially great, as 
this study shows. Clarke and 
colleagues reveal the roles 
of three microRNA (miRNA) 
clusters in the regulation of 
self-renewal in both cancer 
stem cells and normal stem 
cells. Importantly, they show 
that the mRNA encoding BMI1, a criti-
cal promoter of stem cell self-renewal, 
is specifically targeted by this miRNA 
family cluster (Figure 1).
The cancer stem cell hypothesis posits 
that only a subset of cells, endowed with 
stem cell functional properties that are 
not present in the majority of the tumor 
cells, drives clonal neoplastic growth. It 
is therefore evident that the molecular 
pathways operational in these cells must 
be unique from those in the bulk of the 
tumor, but such pathways will remain 
elusive unless these cells can be purified 
and studied separately from bulk tumor 
cells. Although not all human cancers 
may contain rare populations of tumori-
genic cells, human breast cancer and 
genetically engineered mouse models 
of breast cancer do have relatively rare 
populations of tumorigenic cells that are 
responsible for tumor propagation (Al-
Hajj et al., 2003; Cho et al., 2008). The 
emergence of miRNAs, as an additional 
cellular epigenetic mechanism and layer 
of control for gene expression (Ventura 
and Jacks, 2009), has spurred studies 
to investigate whether miRNAs play an 
important role in the cancer stem cell 
phenotype. The exquisite regulation that 
stem cells must exert to control self-
renewal strongly suggests that miRNAs 
could provide an important additional 
level of molecular control. Parallels 
between cancer stem cells and normal 
stem cells are strong, and miRNA mech-
anisms could be predicted to be shared.
Following purification of breast cancer-
initiating cells from human breast tumor 
samples, Clarke and colleagues used mul-
tiplex real-time PCR to study the expres-
sion of 460 miRNAs. After choosing a 
smaller subset of 37 miRNAs and testing 
them on a larger number of samples, three 
miRNA clusters were identified that had 
decreased expression in freshly isolated 
CD44+CD24−/low breast cancer 
cells compared to cells in the 
tumor bulk. The same miRNA 
clusters were found to be 
downregulated in normal mam-
mary epithelial stem cells, and 
similar seed sequences were 
shared by two of the three clus-
ters. MicroRNA target predic-
tion, using the tool Targetscan 
4.2, identified the 3′UTR of 
BMI1 as the component linking 
the function of these miRNAs 
to molecular control of stem 
cell self-renewal.
In particular, one of the 
miRNAs, miR-200c, was 
shown to interact directly 
with the 3′UTR of BMI1, in a 
translation initiation reporter 
assay, and to decrease production of the 
BMI1 protein. Most importantly, overex-
pression of miR-200c was shown to have 
functional consequences for both normal 
stem cell and breast cancer stem cell 
function in vitro and in vivo, restraining 
clonogenic and tumor-initiating activi-
ties. Genetic loss of function of BMI1 is 
well known to attenuate the self-renewal 
properties of normal stem cell and can-
cer stem cell populations.
Figure 1. MicroRNAs Target BMI1 to Block Self-Renewal
MicroRNA-200c (miR-200c) shows decreased expression in breast cancer 
stem cells compared to cancer cells in the bulk tumor. Normal mammary epi-
thelial stem cells show lower expression of miR-200c than differentiated cells. 
It is possible that miR-200c blocks stem cell self-renewal by targeting the 
3′UTR of the self-renewal gene BMI1, resulting in loss of BMI1 protein,and 
attenuation of the ability of cancer stem cells to self-renew and form tumors.Cell 138, August 7, 2009 ©2009 Elsevier Inc. 423
These findings make several impor-
tant contributions. First, they provide 
additional data showing the critical 
regulatory roles that miRNAs play in 
cancer biology (Ventura and Jacks, 
2009) and, in particular, stem cell 
biology. Recently, in human embry-
onic stem cells, increased expression 
of miR-145 in clusters of these cells 
called embryoid bodies was shown to 
target the 3′UTRs of mRNAs encoding 
pluripotency factors, resulting in the 
promotion of differentiation and loss 
of self-renewal (Xu et al., 2009). In the 
new study, identical miRNA clusters are 
suppressed in both normal mammary 
epithelial stem cells and human breast 
tumor-initiating cells, demonstrating 
the close similarities in molecular regu-
latory controls that are used by stem 
cells and their malignant counterparts. 
Again, it is shown that stem cell regula-
tory pathways are the same as cancer 
stem cell regulatory pathways. Second, 
the new data demonstrate an important 
additional layer of regulatory control 
that is exerted on BMI1. As the miRNA 
clusters are located on three distinct 
chromosomal regions, the authors 
rightly point out the advantages of 
such an organization, providing layers 
of back up to restrain BMI1 activity in 
inappropriate cell populations.424 Cell 138, August 7, 2009 ©2009 Elsevier
Diabetes results from loss of the insulin-
producing beta cells of the pancreatic 
islets. A clear identification of the pro-
genitor cell population that gives rise to 
beta cells and an understanding of the 
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ferentiate into beta cells.As with many other miRNA studies and 
because this is a new and rapidly evolv-
ing field, many questions remain. Obvi-
ously, many other targets of these three 
miRNA clusters exist and the importance 
of these other targets in determining 
the effects of expression of the miRNA 
clusters remains to be defined. Mecha-
nisms that regulate the expression of 
miRNAs during stem cell differentiation 
are not known. Also, functional data are 
shown only for one of the miRNA spe-
cies, and it would be valuable to know 
the effectiveness of different members 
of the miR-200c cluster in suppress-
ing BMI1 translation or effecting BMI1 
mRNA degradation. Although the effects 
of miR-200c also are shown in a tera-
tocarcinoma (Tera-2) cell line, it is likely 
that completely distinct milieus exist 
for miRNA expression and targeting 
in distinct cell types, and it is not clear 
whether targeting BMI1 is as important 
in these cell types. As well, the promo-
tion of differentiation by miR-200c in 
Tera-2 cells may be a unique effect in 
this particular cell type. A role for miR-
200c in the induction of differentiation in 
normal mammary epithelial stem cells is 
less clear, and it is not known whether 
miR-200c is actually required for the pro-
duction of differentiated cell types or just 
blocks self-renewal. Inc.
factors and the cellular mechanisms that 
govern beta cell regeneration may lead 
to new and more effective treatments 
for diabetes. The paired homeobox tran-
scription factor Pax4 has been implicated 
et Beta Cells
achusetts General Hospital, Boston, MA 02114
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lin-producing beta cells of the pa
t al. (2009) now show that in resp
give rise to glucagon-expressingThe Shimono et al. study is the first to 
identify roles for specific miRNAs in parallel 
populations of stem cells and in their neo-
plastic counterparts. This field of research 
is likely to be a rich but complex arena for 
studying mechanisms of stem cell func-
tion, particularly in cancer stem cells. It 
will be especially interesting to determine 
whether miRNA genes are directly tar-
geted, either alone or cooperatively, dur-
ing cancer initiation in normal stem cells 
or progenitor cells, or whether they are 
altered later in the neoplastic process and 
so contribute to tumor progression. The 
new work also suggests that therapeu-
tic approaches involving manipulation of 
miRNA expression may be another strat-
egy to target cancer stem cells.
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